Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration
- 1 May 2009
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Opthalmology
- Vol. 20 (3), 223-225
- https://doi.org/10.1097/icu.0b013e328329b656
Abstract
To report the safety and efficacy of intravitreal injections for age-related macular degeneration (AMD). Injecting antivascular endothelial growth factor drugs into the vitreal cavity brings new hope to many AMD patients. Currently, several antivascular endothelial growth factor drugs such as pegaptanib, ranibizumab, and bevacizumab are used via the intravitreal route for neovascular AMD. However, these injections are not without ocular or systemic complications. Review of current literature suggests that intravitreal antivascular endothelial growth factor agents are generally a safe and effective treatment for neovascular AMD for up to 2-3 years. Presently, there is level I evidence to substantiate this conclusion for pegaptanib and ranibizumab, but not bevacizumab.Keywords
This publication has 18 references indexed in Scilit:
- Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1American Journal of Ophthalmology, 2008
- Emerging Therapies for Neovascular Age-Related Macular Degeneration: State of the ArtOphthalmologica, 2007
- Pegaptanib 1-Year Systemic Safety Results from a Safety–Pharmacokinetic Trial in Patients with Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- Subgroup Analysis of the MARINA Study of Ranibizumab in Neovascular Age-Related Macular DegenerationOphthalmology, 2007
- Overview of Progress in the Epidemiology of Age-Related Macular DegenerationOphthalmic Epidemiology, 2007
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Intravitreal Triamcinolone Acetonide: A Change in a ParadigmOphthalmic Research, 2006
- Pegaptanib for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2004
- The Epidemiology of Age-Related Macular DegenerationInternational Ophthalmology Clinics, 2004
- Age-Related Macular Degeneration and Blindness due to Neovascular MaculopathyAmerican Journal of Ophthalmology, 1984